{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T18:22:39Z","timestamp":1787682159607,"version":"build-2784847793"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T00:00:00Z","timestamp":1766534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Med"],"DOI":"10.1038\/s43856-025-01327-2","type":"journal-article","created":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T16:55:26Z","timestamp":1766595326000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["In-situ dual-lighting system for HER2 nucleic acid and protein co-localization through simultaneous visual signal amplification in single pathological sections"],"prefix":"10.1038","volume":"6","author":[{"given":"Tiantian","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5287-264X","authenticated-orcid":false,"given":"Qingling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiyang","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qunyue","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,24]]},"reference":[{"key":"1327_CR1","doi-asserted-by":"crossref","unstructured":"Ko, H. C. et al. From tissue-specific to tissue-agnostic: HER2 overexpression and the rise of antibody-drug conjugates. Front. Oncol. 15, (2025).","DOI":"10.3389\/fonc.2025.1565872"},{"key":"1327_CR2","unstructured":"Albagoush, S. A., Zubair, M. & Limaiem, F. Tissue Evaluation for HER2 Tumor Marker. in StatPearls (StatPearls Publishing, Treasure Island (FL), (2025)."},{"key":"1327_CR3","doi-asserted-by":"publisher","first-page":"157910","DOI":"10.1016\/j.cej.2024.157910","volume":"502","author":"J Liu","year":"2024","unstructured":"Liu, J. et al. Integrated dual-biomarker detection: Transforming proteins and nucleic acids into ssDNA for enhanced disease diagnosis. Chem. Eng. J. 502, 157910 (2024).","journal-title":"Chem. Eng. J."},{"key":"1327_CR4","doi-asserted-by":"publisher","first-page":"eabq4964","DOI":"10.1126\/science.abq4964","volume":"381","author":"D Bressan","year":"2023","unstructured":"Bressan, D., Battistoni, G. & Hannon, G. J. The dawn of spatial omics. Science 381, eabq4964 (2023).","journal-title":"Science"},{"key":"1327_CR5","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1038\/s41587-022-01483-z","volume":"40","author":"S He","year":"2022","unstructured":"He, S. et al. High-plex imaging of RNA and proteins at subcellular resolution in fixed tissue by spatial molecular imaging. Nat. Biotechnol. 40, 1794\u20131806 (2022).","journal-title":"Nat. Biotechnol."},{"key":"1327_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-56653-9","volume":"16","author":"T Hu","year":"2025","unstructured":"Hu, T. et al. NAPTUNE: nucleic acids and protein biomarkers testing via ultra-sensitive nucleases escalation. Nat. Commun. 16, 1331 (2025).","journal-title":"Nat. Commun."},{"key":"1327_CR7","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1016\/j.cell.2020.10.026","volume":"183","author":"Y Liu","year":"2020","unstructured":"Liu, Y. et al. High-Spatial-Resolution Multi-Omics Sequencing via Deterministic Barcoding in Tissue. Cell 183, 1665\u20131681.e18 (2020).","journal-title":"Cell"},{"key":"1327_CR8","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1038\/s41588-021-00911-1","volume":"53","author":"SZ Wu","year":"2021","unstructured":"Wu, S. Z. et al. A single-cell and spatially resolved atlas of human breast cancers. Nat. Genet. 53, 1334\u20131347 (2021).","journal-title":"Nat. Genet."},{"key":"1327_CR9","doi-asserted-by":"publisher","first-page":"158452","DOI":"10.1016\/j.cej.2024.158452","volume":"503","author":"Y Zhang","year":"2025","unstructured":"Zhang, Y. et al. Simultaneous detection of protein and nucleic acid biomarkers with a CRISPR-based assay. Chem. Eng. J. 503, 158452 (2025).","journal-title":"Chem. Eng. J."},{"key":"1327_CR10","doi-asserted-by":"publisher","DOI":"10.1126\/science.aay9040","volume":"375","author":"D Crosby","year":"2022","unstructured":"Crosby, D. et al. Early detection of cancer. Science 375, eaay9040 (2022).","journal-title":"Science"},{"key":"1327_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36137-4","volume":"14","author":"Y Tao","year":"2023","unstructured":"Tao, Y. et al. Highly efficient and robust \u03c0-FISH rainbow for multiplexed in situ detection of diverse biomolecules. Nat. Commun. 14, 443 (2023).","journal-title":"Nat. Commun."},{"key":"1327_CR12","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S0304-3835(97)00326-1","volume":"118","author":"JW Park","year":"1997","unstructured":"Park, J. W. et al. Anti-HER2 immunoliposomes for targeted therapy of human tumors. Cancer Lett. 118, 153\u2013160 (1997).","journal-title":"Cancer Lett."},{"key":"1327_CR13","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1002\/ijc.30870","volume":"141","author":"N Takegawa","year":"2017","unstructured":"Takegawa, N. et al. DS-8201a, a new HER2-targeting antibody-drug conjugate incorporating a novel DNA topoisomerase I inhibitor, overcomes HER2-positive gastric cancer T-DM1 resistance. Int. J. Cancer 141, 1682\u20131689 (2017).","journal-title":"Int. J. Cancer"},{"key":"1327_CR14","doi-asserted-by":"publisher","first-page":"S81","DOI":"10.1093\/annonc\/12.suppl_1.S81","volume":"12","author":"S Scholl","year":"2001","unstructured":"Scholl, S., Beuzeboc, P. & Pouillart, P. Targeting HER2 in other tumor types. Ann. Oncol. 12, S81\u2013S87 (2001).","journal-title":"Ann. Oncol."},{"key":"1327_CR15","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1016\/S0140-6736(16)32417-5","volume":"389","author":"S Loibl","year":"2017","unstructured":"Loibl, S. & Gianni, L. HER2-positive breast cancer.  Lancet 389, 2415\u20132429 (2017).","journal-title":"Lancet"},{"key":"1327_CR16","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.2217\/fon.14.19","volume":"10","author":"V Martin","year":"2014","unstructured":"Martin, V., Cappuzzo, F., Mazzucchelli, L. & Frattini, M. HER2 in solid tumors: more than 10 years under the microscope; where are we now?. Future Oncol. 10, 1469\u20131486 (2014).","journal-title":"Future Oncol."},{"key":"1327_CR17","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1309\/AJCPV2I0HGPMGBSQ","volume":"132","author":"F Penault-Llorca","year":"2009","unstructured":"Penault-Llorca, F. et al. Emerging technologies for assessing HER2 amplification. Am. J. Clin. Pathol. 132, 539\u2013548 (2009).","journal-title":"Am. J. Clin. Pathol."},{"key":"1327_CR18","doi-asserted-by":"publisher","first-page":"4619","DOI":"10.3748\/wjg.v22.i19.4619","volume":"22","author":"LF Abrahao-Machado","year":"2016","unstructured":"Abrahao-Machado, L. F. & Scapulatempo-Neto, C. HER2 testing in gastric cancer: An update. World J. Gastroenterol. 22, 4619\u20134625 (2016).","journal-title":"World J. Gastroenterol."},{"key":"1327_CR19","doi-asserted-by":"publisher","first-page":"5097","DOI":"10.1158\/1078-0432.CCR-15-2822","volume":"22","author":"Y Ogitani","year":"2016","unstructured":"Ogitani, Y. et al. DS-8201a, A Novel HER2-Targeting ADC with a Novel DNA Topoisomerase I Inhibitor, Demonstrates a Promising Antitumor Efficacy with Differentiation from T-DM1. Clin. Cancer Res. 22, 5097\u20135108 (2016).","journal-title":"Clin. Cancer Res."},{"key":"1327_CR20","doi-asserted-by":"publisher","first-page":"4478","DOI":"10.1158\/1078-0432.CCR-20-4557","volume":"27","author":"P Narayan","year":"2021","unstructured":"Narayan, P. et al. FDA Approval Summary: Fam-Trastuzumab Deruxtecan-Nxki for the Treatment of Unresectable or Metastatic HER2-Positive Breast Cancer. Clin. Cancer Res. 27, 4478\u20134485 (2021).","journal-title":"Clin. Cancer Res."},{"key":"1327_CR21","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1093\/oncolo\/oyae151","volume":"29","author":"GU Mehta","year":"2024","unstructured":"Mehta, G. U. et al. FDA approval summary: fam-trastuzumab deruxtecan-nxki for unresectable or metastatic non-small cell lung cancer with activating HER2 mutations.  Oncologist 29, 667\u2013671 (2024).","journal-title":"Oncologist"},{"key":"1327_CR22","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1200\/JCO.2018.77.8738","volume":"36","author":"AC Wolff","year":"2022","unstructured":"Wolff, A. C. et al. Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology\/College of American Pathologists Clinical Practice Guideline Focused Update. J. Clin. Oncol. 36, 2105\u20132122 (2022).","journal-title":"J. Clin. Oncol."},{"key":"1327_CR23","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.annonc.2023.05.008","volume":"34","author":"P Tarantino","year":"2023","unstructured":"Tarantino, P. et al. ESMO expert consensus statements (ECS) on the definition, diagnosis, and management of HER2-low breast cancer. Ann. Oncol. 34, 645\u2013659 (2023).","journal-title":"Ann. Oncol."},{"key":"1327_CR24","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1200\/JCO.19.02488","volume":"38","author":"P Tarantino","year":"2020","unstructured":"Tarantino, P. et al. HER2-Low breast cancer: pathological and clinical landscape. J. Clin. Oncol. 38, 1951\u20131962 (2020).","journal-title":"J. Clin. Oncol."},{"key":"1327_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/17588359231152842","volume":"15","author":"E Nicol\u00f2","year":"2023","unstructured":"Nicol\u00f2, E., Boscolo Bielo, L., Curigliano, G. & Tarantino, P. The HER2-low revolution in breast oncology: steps forward and emerging challenges. Ther. Adv. Med. Oncol. 15, 1\u201316 (2023).","journal-title":"Ther. Adv. Med. Oncol."},{"key":"1327_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-024-01899-2","volume":"26","author":"G Nader-Marta","year":"2024","unstructured":"Nader-Marta, G. et al. Clinical characterization, prognostic, and predictive values of HER2-low in patients with early breast cancer in the PALLAS trial (ABCSG-42\/AFT-05\/BIG-14\u201313\/PrE0109). Breast Cancer Res 26, 140 (2024).","journal-title":"Breast Cancer Res"},{"key":"1327_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-93086-2","volume":"15","author":"A Cierzniak","year":"2025","unstructured":"Cierzniak, A., Ma\u0142odobra-Mazur, M. & Tokarski, M. A new approach for the detection of genetic alterations utilizing modified loop-mediated isothermal amplification reaction (LAMP). Sci. Rep. 15, 8071 (2025).","journal-title":"Sci. Rep."},{"key":"1327_CR28","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1111\/j.1440-1827.2007.02144.x","volume":"57","author":"S Ikeda","year":"2007","unstructured":"Ikeda, S., Takabe, K., Inagaki, M., Funakoshi, N. & Suzuki, K. Detection of gene point mutation in paraffin sections using in situ loop-mediated isothermal amplification. Pathol. Int. 57, 594\u2013599 (2007).","journal-title":"Pathol. Int."},{"key":"1327_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0008996","volume":"15","author":"TF Kapalamula","year":"2021","unstructured":"Kapalamula, T. F. et al. Development of a loop-mediated isothermal amplification (LAMP) method for specific detection of Mycobacterium bovis. PLoS Negl. Trop. Dis. 15, e0008996 (2021).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"1327_CR30","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1039\/D5AN00078E","volume":"150","author":"JH Choi","year":"2025","unstructured":"Choi, J. H. et al. Tyramide signal amplification for a highly sensitive multiplex immunoassay based on encoded hydrogel microparticles. Analyst 150, 2118\u20132127 (2025).","journal-title":"Analyst"},{"key":"1327_CR31","first-page":"41","volume":"11","author":"K Kubelka-Sabit","year":"2008","unstructured":"Kubelka-Sabit, K., Prodanova, I., Zografski, G. & Basheska, N. In situ hybridization, with or without tyramide signal amplification, in evaluation of human papillomavirus status inearly stage cervical carcinoma. Balk. J. Med. Genet. 11, 41\u201350 (2008).","journal-title":"Balk. J. Med. Genet."},{"key":"1327_CR32","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/joa.13644","volume":"241","author":"A Alzu\u2019bi","year":"2022","unstructured":"Alzu\u2019bi, A., Sankar, N., Crosier, M., Kerwin, J. & Clowry, G. J. Tyramide signal amplification coupled with multiple immunolabeling and RNAScope in situ hybridization in formaldehyde-fixed paraffin-embedded human fetal brain. J. Anat. 241, 33\u201341 (2022).","journal-title":"J. Anat."},{"key":"1327_CR33","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1080\/22221751.2022.2054368","volume":"11","author":"JN Yang","year":"2022","unstructured":"Yang, J. N. et al. RT-LAMP assay for rapid detection of the R203M mutation in SARS-CoV-2 Delta variant. Emerg. Microbes Infect. 11, 978\u2013987 (2022).","journal-title":"Emerg. Microbes Infect."},{"key":"1327_CR34","doi-asserted-by":"publisher","first-page":"3346","DOI":"10.1021\/acs.analchem.9b05323","volume":"92","author":"M Varona","year":"2020","unstructured":"Varona, M., Eitzmann, D. R., Pagariya, D., Anand, R. K. & Anderson, J. L. Solid-phase microextraction enables isolation of BRAF V600E circulating tumor DNA from human plasma for detection with a molecular beacon loop mediated isothermal amplification assay. Anal. Chem. 92, 3346\u20133353 (2020).","journal-title":"Anal. Chem."},{"key":"1327_CR35","doi-asserted-by":"publisher","first-page":"6040","DOI":"10.1039\/D4MH00660G","volume":"11","author":"Y Guo","year":"2024","unstructured":"Guo, Y. et al. Modulation of intramolecular freedom for tuning fluorescence imaging and photooxidation of amyloid-\u03b2 aggregates. Mater. Horiz. 11, 6040\u20136048 (2024).","journal-title":"Mater. Horiz."},{"key":"1327_CR36","unstructured":"PathVysion HER-2 DNA Probe Kit. https:\/\/www.molecular.abbott\/content\/dam\/add\/molecular\/products\/oncology\/pathvysion-her-2-dna-probe-kit\/30-608377.pdf. (Accessed 8 March (2025)."},{"key":"1327_CR37","unstructured":"HER2\/CEN17 FISH Probe Kit. https:\/\/www.zytovision.com\/downloads_products\/manuals\/en\/z-2015-ce-ivd-en.pdf. (Accessed 8 March 2025)."},{"key":"1327_CR38","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1093\/ajcp\/aqy171","volume":"151","author":"F Schneider","year":"2019","unstructured":"Schneider, F. et al. The FDA-Approved Breast Cancer HER2 Evaluation Kit (HercepTest; Dako) May Miss Some HER2-Positive Breast Cancers. Am. J. Clin. Pathol. 151, 504\u2013510 (2019).","journal-title":"Am. J. Clin. Pathol."},{"key":"1327_CR39","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1097\/01.pai.0000213138.01536.2e","volume":"15","author":"R Ni","year":"2007","unstructured":"Ni, R., Mulligan, A. M., Have, C. & O\u2019Malley, F. P. PGDS, A Novel Technique Combining Chromogenic In Situ Hybridization and Immunohistochemistry for the Assessment of ErbB2 (HER2\/neu) Status in Breast Cancer. Appl. Immunohistochem. Mol. Morphol. 15, 316 (2007).","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"key":"1327_CR40","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/1746-1596-7-60","volume":"7","author":"H Nitta","year":"2012","unstructured":"Nitta, H. et al. A gene-protein assay for human epidermal growth factor receptor 2 (HER2): brightfield tricolor visualization of HER2 protein, the HER2 gene, and chromosome 17 centromere (CEN17) in formalin-fixed, paraffin-embedded breast cancer tissue sections. Diagn. Pathol. 7, 60 (2012).","journal-title":"Diagn. Pathol."},{"key":"1327_CR41","first-page":"1084","volume":"15","author":"S Ikeda","year":"2018","unstructured":"Ikeda, S. Novel and simple method of double-detection using fluorescence in situ hybridization and fluorescence immunostaining of formalin-fixed paraffin-embedded tissue sections. Oncol. Lett. 15, 1084\u20131088 (2018).","journal-title":"Oncol. Lett."},{"key":"1327_CR42","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s10549-016-3856-2","volume":"158","author":"S Kurozumi","year":"2016","unstructured":"Kurozumi, S. et al. HER2 intratumoral heterogeneity analyses by concurrent HER2 gene and protein assessment for the prognosis of HER2 negative invasive breast cancer patients. Breast Cancer Res. Treat. 158, 99\u2013111 (2016).","journal-title":"Breast Cancer Res. Treat."},{"key":"1327_CR43","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1038\/s41592-021-01203-6","volume":"18","author":"SM Lewis","year":"2021","unstructured":"Lewis, S. M. et al. Spatial omics and multiplexed imaging to explore cancer biology. Nat. Methods 18, 997\u20131012 (2021).","journal-title":"Nat. Methods"},{"key":"1327_CR44","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/s41551-020-0576-z","volume":"4","author":"N Tanaka","year":"2020","unstructured":"Tanaka, N. et al. Three-dimensional single-cell imaging for the analysis of RNA and protein expression in intact tumour biopsies. Nat. Biomed. Eng. 4, 875\u2013888 (2020).","journal-title":"Nat. Biomed. Eng."},{"key":"1327_CR45","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41587-020-0472-9","volume":"38","author":"CR Merritt","year":"2020","unstructured":"Merritt, C. R. et al. Multiplex digital spatial profiling of proteins and RNA in fixed tissue. Nat. Biotechnol. 38, 586\u2013599 (2020).","journal-title":"Nat. Biotechnol."}],"container-title":["Communications Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-01327-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-01327-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-01327-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T15:05:26Z","timestamp":1769612726000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-01327-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,24]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1327"],"URL":"https:\/\/doi.org\/10.1038\/s43856-025-01327-2","relation":{},"ISSN":["2730-664X"],"issn-type":[{"value":"2730-664X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,24]]},"assertion":[{"value":"2 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"64"}}